We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Golden Grail Technology Corporation (PK) | USOTC:GOGY | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0024 | 7.25% | 0.0355 | 0.0253 | 0.077 | 0.0436 | 0.031 | 0.0336 | 44,582 | 22:00:01 |
DEERFIELD BEACH, FL -- March 29th, 2017 -- InvestorsHub NewsWire -- Golden Grail Technology Corp. (OTC Markets:(GOGY) (Golden Grail or the Company), a technology and software solutions provider to companies with unique value propositions operating in mass market consumer sectors, is extremely pleased to announce the execution of a Medical Practice Distribution Agreement between its subsidiary Accurate Venture and Southwest Cancer Center at Florida Hospital in Orlando Florida. The five-doctor practice is one of the most prestigious in the area and services thousands of patients.
In February 2016, Golden Grail Technology acquired Accurate Venture, which develops and markets specific consumer and pharmaceutical grade Hemp Cannabidiol (CBD) supplement products. Accurate has a large marketing database of customers and offers monthly subscriptions for most of its product line.
The Agreement reduces the cost of Accurate Ventures bioRenovate 1500mg pharmaceutical grade CBD product for all Oncology patients under Southwest Cancer Centers care.
and grants specific rights for the practice to grant a limited number of pro-bono bottles to people who are less fortunate, under the Karenna program. The Karenna program allows for a certain percentage of bottles to be given at no cost to patients, at the discretion of the doctors.
Dr. Sarah Katta, commented, We are honored to have bioRenovate available here at Southwest Cancer Center. bioRenovate is the only true pharmaceutical grade cannabis product that I trust enough to give it to my patients. They are rigorously tested for quality and maintain the highest standards. This will improve the quality of life and help may patients who have very little hope otherwise. Im pleased to offer it to our patient population.
Chief Executive Officer Bill Fisher commented, Southwest Cancer Center is one of the most respected practices in the region and itsmore than an honor to have the practice on-board. This is the first in a long line of practices across the country that we are working diligently to get distribution deals signed with and add quality of life to patients across the entire United States.
We are also happy to announce the start of the Karenna Program. The Karenna Program gives back 5% of the total bottles distributed through each location, to various less fortunate people who cannot afford the product. Fisher continued, We cant tell you how excited we are to help people who normally can not afford the product at some level. This program will not only be at Southwest Cancer Center, we will be rolling this out nation-wide.
About Southwest Cancer Center
Southwest Cancer Center was established by Dr. Thomas Katta in 1984 and has been serving Orlando for 33 years. They specialize in Hematology/Oncology and are one of the highest rated practices in the region. There are five doctors and two locations in Orlando and they serve thousands of patients, 922 Lucerne Terrace Orlando FL 32806 and 7436 Docs Grove Circle Orlando FL 32819.
About bioRenovate 1500mg 1oz Sublingual Drops
bioRenovate 1500 is a 1500mg CBD sublingual tincture produced according to pharmaceutical grade standards and testing. It is available primarily through doctors offices and medical practices with on-line refills can be ordered according to the recommendations of the doctor. Cannabidiol from hemp is Federally legal to distribute across all 50 states, as it is not extracted from the plant that is legally classified as marijuana. bioRenovate products consist solely of parts of the cannabis plant excluded from the CSA definition of marijuana, and therefore are not included in the new drug code (7350) or in the drug code for marijuana (7360).
They are 3rd party verified by the most respected labs in the country and manufactured according to pharmaceutical standards and testing.
About Golden Grail Technology Corp.
Golden Grail Technology Corp. (GOGY) is a technology and software solutions provider to companies with unique value propositions operating in mass market consumer sectors such as jewelry, health and personal care, beauty, electronics, pet and animal supplies, sports and games. Golden Grail's mission is to utilize their network of industry experts, who specialize in targeting areas of business that can be accelerated with technology, in order to give small companies an opportunity to compete with industry giants.
[Doctors recommending bioRenovate products, do so on their own. Accurate Venture and Golden Grail Technology do not make claims of any specific benefits. The Food and Drug Administration has not evaluated representations regarding the efficacy and safety of bioRenovate products. The FDA only evaluates foods and drugs, not supplements like these products. These products are not intended to diagnose, prevent, treat, or cure any disease.]
For more information, please visit: http://goldengrailtechnology.com, http://accurateventure.com, http://biorenovate.com
Forward-Looking Statements
Except for the historical and present factual information contained in this press release, the matters discussed in this press release, including statements identified by words such as "will," "expected," "plans," and similar expressions are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements, including the factors described in filings with OTC Markets, including but not limited to discussion under the caption "Risk Factors." Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment solely as of the date hereof.
Contact Information
Hayden IR
(917) 658-7878
1 Year Golden Grail Technology (PK) Chart |
1 Month Golden Grail Technology (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions